Health In Tech Director Timothy Hayes Sells 17,730 Shares

What Happened
Timothy Hayes, a director of Health In Tech, sold a total of 17,730 shares in two open‑market transactions. On 2026-09-09 he sold 5,730 shares at $0.93 each for $5,329, and on 2026-09-11 he sold 12,000 shares at $0.91 each for $10,920, for combined proceeds of approximately $16,249. These were sales (not purchases), which are commonly routine insider liquidity events rather than an explicit signal about company prospects.

Key Details

• Transaction dates and prices:
  • 2026-09-09: Sold 5,730 shares at $0.93 — $5,329 proceeds
  • 2026-09-11: Sold 12,000 shares at $0.91 — $10,920 proceeds
• Transaction type: Open‑market sales (Form 4 code S)
• Shares owned after transaction: Not specified in the information provided in this summary
• Footnotes/plans: The filing did not indicate a 10b5‑1 plan, tax‑withholding disposition, or other special footnotes
• Filing: Form 4 was filed with the SEC on 2026-09-11; based on the trade and filing dates, the report appears to have been submitted within the typical reporting window

Context
Sales by directors can be routine (cash needs, portfolio management, or diversification) and do not by themselves prove a change in company fundamentals. For retail investors, purchases typically carry more informational weight than routine sales; treat this as a disclosed liquidity event by a director rather than definitive insider sentiment.